Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Alzheimer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05527288
What this trial is testing

A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population

Who this might be right for
Alzheimer DiseaseDementiaBrain Diseases+6 more
Sinotau Pharmaceutical Group 50
Large-scale testing (Phase 3)Study completedNCT01249196
What this trial is testing

A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
SK Chemicals Co., Ltd. 256
Testing effectiveness (Phase 2)Ended earlyNCT00895895
What this trial is testing

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease

Who this might be right for
Alzheimer Disease
Pfizer 526
Early research (Phase 1)Study completedNCT02910739
What this trial is testing

An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)

Who this might be right for
Amnestic Mild Cognitive ImpairmentAlzheimer's DiseaseProdromal Alzheimer's Disease
Merck Sharp & Dohme LLC 16
Testing effectiveness (Phase 2)UnknownNCT05194163
What this trial is testing

MW150 Stress Kinase Inhibitor in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Neurokine Therapeutics 24
Testing effectiveness (Phase 2)Study completedNCT02560753
What this trial is testing

Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
T3D Therapeutics, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT00357357
What this trial is testing

European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Hunter-Fleming Ltd 40
Large-scale testing (Phase 3)Study completedNCT01561053
What this trial is testing

Evaluate Albumin and Immunoglobulin in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Instituto Grifols, S.A. 347
Large-scale testing (Phase 3)Study completedNCT04488419
What this trial is testing

ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia of Alzheimer Type
LeonaBio 554
Testing effectiveness (Phase 2)Study completedNCT04052737
What this trial is testing

PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia
Pharmazz, Inc. 80
Large-scale testing (Phase 3)UnknownNCT00314912
What this trial is testing

Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Bellus Health Inc. - a GSK company 650
Testing effectiveness (Phase 2)Study completedNCT02079909
What this trial is testing

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)

Who this might be right for
Alzheimer's Disease
FUJIFILM Toyama Chemical Co., Ltd. 482
Post-approval studies (Phase 4)Study completedNCT00549601
What this trial is testing

Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis 142
Testing effectiveness (Phase 2)Study completedNCT00285025
What this trial is testing

Study of the Effect of SR57667B in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Sanofi 500
Early research (Phase 1)Study completedNCT00087789
What this trial is testing

CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sangamo Therapeutics 10
Not applicableActive Not RecruitingNCT06160908
What this trial is testing

Transcranial Near-infrared Light Therapy for Mild-Moderate Alzheimer's Disease (NIR4AD)

Who this might be right for
Alzheimer Disease
Xuanwu Hospital, Beijing 38
Testing effectiveness (Phase 2)Study completedNCT05269173
What this trial is testing

Efficacy and Safety of Flos Gossypii Flavonoids Tablet in the Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Capital Medical University 240
Testing effectiveness (Phase 2)Ended earlyNCT01690195
What this trial is testing

Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 343
Testing effectiveness (Phase 2)Ended earlyNCT00299988
What this trial is testing

Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Weill Medical College of Cornell University 24
Not applicableWithdrawnNCT03352024
What this trial is testing

Impact of Hypno-analgesia on Pain During a Lumbar Puncture for Diagnosis of Alzheimer's Disease

Who this might be right for
Cognitive ImpairmentAlzheimer Disease
University Hospital, Montpellier
Next Page